摘要
目的:探讨苯磺酸氨氧地平在社区治疗轻中度高血压中的应用价值。方法:收治轻中度高血压患者200例,平分为苯磺酸氨氧地平组和硝苯地平组。将两组的血压、临床疗效、不良反应发生情况进行统计分析。结果:治疗后和硝苯地平组相比,苯磺酸氨氧地平组的收缩压、舒张压均显著降低(P<0.05)。苯磺酸氨氧地平组治疗的总有效率95.0%,显著高于硝苯地平组的80.0%(P<0.05);不良反应发生率2.0%,显著低于硝苯地平组的10.0%(P<0.05)。结论:苯磺酸氨氧地平在社区治疗轻中度高血压中的应用价值较硝苯地平高。
Objective:To explore the value of amioxdipine besylate in the treatment of mild to moderate hypertension in community.Methods:200 patients with mild to moderate hypertension were selected.They were divided into the amioxdipine besylate group and the nifedipine group.We made the statistical analysis of the blood pressure,clinical effect and the occurrence of adverse reactions in the two groups.Results:Compared with the nifedipine group after treatment,the systolic pressure and diastolic pressure of the amioxdipine besylate group were significantly lower(P〈0.05).The total effective rate of treatment in the amioxdipine besylate group was 95% significantly higher than that of the nifedipine group of 80%(P〈0.05).The incidence of adverse reaction was 2% significantly lower than that of the nifedipine group of 10%(P〈0.05).Conclusion:The value of amlodipine besylate in the treatment of mild to moderate hypertension in the community is higher than nifedipine.
作者
余丽萍
Yu Liping(Integrated Traditional Chinese and Western Medicine Hospital of Wuzhou City,Guangxi 54300)
出处
《中国社区医师》
2018年第16期82-83,共2页
Chinese Community Doctors
关键词
苯磺酸氨氧地平
社区
轻中度高血压
Amioxdipine besylate
Community
Mild to moderate hypertension
Application value